Transcriptional and post-transcriptional regulation of β-secretase

IUBMB Life

Volumn 64, Issue 12, 2012, Pages 943-950

  Tamagno, Elena ^a   Guglielmotto, M ^a   Monteleone, D ^a,b   Vercelli, A ^a   Tabaton, M ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

amyloid; Alzheimer's disease; BACE1

Indexed keywords

3 NITROPROPIONIC ACID; 4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; 4 HYDROXYNONENAL; ANTIINFLAMMATORY AGENT; BETA SECRETASE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEOXYGLUCOSE; GAMMA SECRETASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOSIDINE; PROTEIN C JUN; PROTEIN PRECURSOR; PYRIDINIUM DERIVATIVE; REACTIVE OXYGEN METABOLITE; TETRACYCLINE DERIVATIVE; TRANSCRIPTION FACTOR SP1; UBIQUITIN THIOLESTERASE;

5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOSIS; ASTROCYTE; ATAXIA; BRAIN CAPILLARY; CELL DEATH; CELLS; CRYSTAL STRUCTURE; ENDOSOME; ENDOTHELIUM CELL; ENZYME ACTIVITY; EPILEPSY; GENETIC TRANSCRIPTION; GOLGI COMPLEX; HUMAN; LIPID PEROXIDATION; LYSOSOME; MOLECULAR WEIGHT; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PARAPLEGIA; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANS GOLGI NETWORK; TRANSGENIC MOUSE; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; BRAIN; HUMANS; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84870219993     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1099     Document Type: Review

References (113)

1. Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., et al. (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14, 419-427. (Pubitemid 30026585)
2. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., et al. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540.
3. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
4. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537.
5. Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., et al. (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 97, 1456-1460. (Pubitemid 30118462)
6. Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S, et al. (2000) Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290, 150-153.
7. Evin, G., Lessene, G., and, Wilkins, S., (2011) BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity. Recent Pat. CNS Drug Discov. 6, 91-106.
8. Creemers, J. W., Ines Dominguez, D., Plets, E., Serneels, L., Taylor, N. A., et al. (2001) Processing of beta-secretase by furin and other members of the proprotein convertase family. J. Biol. Chem. 276, 4211-4217.
9. Haniu, M., Denis, P., Young, Y., Mendiaz, E. A., Fuller, J., et al. (2000) Characterization of Alzheimer's beta-secretase protein BACE. A pepsin family member with unusual properties. J. Biol. Chem. 275, 21099-21106. (Pubitemid 30481802)
10. Charlwood, J., Dingwall, C., Matico, R., Hussain, I., Johanson, K., et al. (2001) Characterization of the glycosylation profiles of Alzheimer's beta-secretase protein Asp-2 expressed in a variety of cell lines. J. Biol. Chem. 276, 16739-16748.
11. Capell, A., Steiner, H., Willem, M., Kaiser, H., Meyer, C., et al. (2000) Maturation and pro-peptide cleavage of beta-secretase. J. Biol. Chem. 275, 30849-30854.
12. Benjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J. S., et al. (2001) Post-translational processing of beta-secretase (beta-amyloid- converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem. 276, 10879-10887. (Pubitemid 38089265)
13. Pinnix, I., Council, J. E., Roseberry, B., Onstead, L., Mallender, W., et al. (2001) Convertases other than furin cleave beta-secretase to its mature form. FASEB J. 15, 1810-1812.
14. Holsinger, R. M., McLean, C. A., Beyreuther, K., Masters, C. L., and, Evin, G., (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann. Neurol. 51, 783-786. (Pubitemid 34568861)
15. Fukumoto, H., Cheung, B. S., Hyman, B. T., and, Irizarry, MC., (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 1381-1389. (Pubitemid 35014802)
16. Yang, L. B., Lindholm, K., Yan, R., Citron, M., Xia, W., et al. (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 3-4. (Pubitemid 36098241)
17. Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., et al. (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 8, 1-13.
18. Huang, X., Moir, R. D., Tanzi, R. E., Bush, A. I., and, Rogers, J. T., (2004) Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. N Y Acad. Sci. 1012, 153-163. (Pubitemid 38453522)
19. Cai, Z., Zhao, B., and, Ratka, A., (2011) Oxidative stress and β-amyloid protein in Alzheimer's disease. Neuromol. Med. 13, 223-250.
20. Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., et al. (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10, 279-288. (Pubitemid 35217581)
21. Tamagno, E., Guglielmotto, M., Bardini, P., Santoro, G., Davit, A., et al. (2003) Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress. Neurobiol. Dis. 14, 291-301. (Pubitemid 37311292)
22. Tamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., et al. (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92, 628-636. (Pubitemid 40189465)
23. Tamagno, E., Guglielmotto, M., Aragno, M., Borghi, R., Autelli, R., et al. (2008) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J. Neurochem. 104, 683-695.
24. Jo, D. G., Arumugam, T. V., Woo, H. N., Park, J. S., Tang, S. C., et al. (2010) Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease. Neurobiol. Aging 31, 917-925.
25. Verri, M., Pastoris, O., Dossena, M., Aquilani, R., Guerriero, F., et al. (2012) Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimers disease. Int. J. Immunopathol. Pharmacol. 25, 345-353.
26. Sastre, M., Dewachter, I., Rossner, S., Bogdanovic, N., Rosen, E., et al. (2006) Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proc. Natl. Acad. Sci. USA. 103, 443-448. (Pubitemid 43122420)
27. Giliberto, L., Borghi, R., Piccini, A., Mangerini, R., Sorbi, S., et al. (2009) Mutant presenilin 1 increases the expression and activity of BACE1. J. Biol. Chem. 284, 9027-9038.
28. 42 activates the expression of BACE1 through the JNK pathway. J. Alzheimers Dis. 27, 871-883.
29. Piccini, A., Zanusso, G., Borghi, R., Noviello, C., Monaco, S., et al. (2007) Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype. Arch. Neurol. 64, 738-745. (Pubitemid 46789842)
30. Assini, A., Terreni, L., Borghi, R., Giliberto, L., Piccini, A., et al. (2003) Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation. Neurology 60, 150-151. (Pubitemid 36070672)
31. Takao, M., Ghetti, B., Murrell, J. R., Unverzagt, F. W., Giaccone, G., et al. (2001) Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J. Neuropathol. Exp. Neurol. 60, 1137-1152. (Pubitemid 33117095)
32. Liu, K., Doms, R. W., and, Lee, V. M., (2002) Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression. Biochemistry 41, 3128-3136. (Pubitemid 34184644)
33. Schilling, S., Lauber, T., Schaupp, M., Manhart, S., Scheel, E., et al. (2006) On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 45, 12393-12399. (Pubitemid 44583682)
34. Piccini, A., Russo, C., Ghiozzi, A., Relini, A., Vitali, A., et al. (2005) Beta-amyloid is different in normal aging and in Alzheimer disease. J. Biol. Chem. 280, 34186-34192. (Pubitemid 41443143)
35. Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and Host. Science 313, 1781-1784. (Pubitemid 44454153)
36. Tabaton, M., and, Gambetti, P., (2006) Soluble amyloid-beta in the brain: the scarlet pimpernel. J. Alzheimers Dis. 9, 127-132. (Pubitemid 44253306)
37. Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W. M., and, Mattson, M. P., (2005) Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307, 262-265. (Pubitemid 40116242)
38. Sambamurti, K., Kinsey, R., Maloney, B., Ge, Y. W., and, Lahiri, D. K., (2004) Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 18, 1034-1036. (Pubitemid 39561516)
39. Christensen, M. A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., et al. (2004) Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol. Cell. Biol. 24, 865-874. (Pubitemid 38057936)
40. Basha, M. R., Wei, W., Bakheet, S. A., Benitez, N., Siddiqi, H. K., et al. (2005) The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci. 25, 823-829. (Pubitemid 40170996)
41. Adwan, L. I., Basha, R., Abdelrahim, M., Subaiea, G. M., and, Zawia, N. H., (2011) Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway. Curr. Alzheimer Res. 8, 385-392.
42. Chu, J., Zhuo, J. M., and, Praticò, D., (2012) Transcriptional regulation of β-secretase-1 by 12/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments. Ann. Neurol. 71, 57-67.
43. Camandola, S., Poli, G., and, Mattson, M. P., (2000) The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons. Brain Res. Mol. Brain Res. 85, 53-60. (Pubitemid 32056236)
44. Mattson, M. P., (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639. (Pubitemid 39061671)
45. Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B., and, Kaltschmidt, C., (1999) Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96, 9409-9414. (Pubitemid 29374768)
46. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., and, Kaltschmidt, C., (1997) Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 2642-2647. (Pubitemid 27136929)
47. Buggia-Prevot, V., Sevalle, J., Rossner, S., and, Checler, F., (2008) NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. J. Biol. Chem. 283, 10037-10047.
48. Guglielmotto, M., Aragno, M., Tamagno, E., Vercellinatto, I., Visentin, S., et al. (2012) AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation. Neurobiol. Aging 33, 196.e13-196.e1327.
49. Granic, I., Dolga, A. M., Nijholt, I. M., van Dijk, G., and, Eisel, U. L., (2009) Inflammation and NF-kappaB in Alzheimer's disease and diabetes. J. Alzheimers Dis. 16, 809-821.
50. Kuang, X., Scofield, V. L., Yan, M., Stoica, G., Liu, N., et al. (2009) Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice. Brain Res. 1286, 174-184.
51. Cai, Z., Zhao, Y., Yao, S., and, Bin Zhao, B., (2011) Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation. Pharmacol. Rep. 63, 381-391.
52. Paris, D., Beaulieu-Abdelahad, D., Bachmeier, C., Reed, J., Ait-Ghezala, G., et al. (2011) Anatabine lowers Alzheimer's Aβ production in vitro and in vivo. Eur. J. Pharmacol. 670, 384-391.
53. Yi, H., Lee, S. J., Lee, J., Myung, C. S., Park, W. K., et al. (2011) Sphingosylphosphorylcholine attenuated β-amyloid production by reducing BACE1 expression and catalysis in PC12 cells. Neurochem. Res. 36, 2083-2090.
54. Chami, L., Buggia-Prévot, V., Duplan, E., Delprete, D., Chami, M., et al. (2012) Nuclear factor-κB regulates βAPP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations. J. Biol. Chem. 287, 24573-24584.
55. Tamagno, E., Guglielmotto, M., Giliberto, L., Vitali, A., Borghi, R., et al. (2009) JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. Neurobiol. Aging 30, 1563-1573.
56. Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y. D., et al. (2009) Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Proc. Natl. Acad. Sci. USA 106, 3907.
57. Grammas, P., Sanchez, A., Tripathy, D., Luo, E., and, Martinez, J., (2011) Vascular signaling abnormalities in Alzheimer disease. Cleve Clin. J. Med. 78, S50-S53.
58. de la Torre, J. C., and, Stefano, G. B., (2000) Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res. Brain Res. Rev. 34, 119-136.
59. Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., et al. (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. USA 103, 18727-18732. (Pubitemid 44913478)
60. Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., et al. (2007) Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem. 282, 10873-10880. (Pubitemid 47100783)
61. Guglielmotto, M., Aragno, M., Autelli, R., Giliberto, L., Novo, E., et al. (2009) The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. J. Neurochem. 108, 1045-1056.
62. Bulbarelli, A., Lonati, E., Brambilla, A., Orlando, A., Cazzaniga, E., et al. (2012) Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation. Mol. Cell Neurosci. 49, 415-422.
63. Li, Q. Y., Wang, H. M., Wang, Z. Q., Ma, J. F., Ding, J. Q., et al. (2010) Salidroside attenuates hypoxia-induced abnormal processing of amyloid precursor protein by decreasing BACE1 expression in SH-SY5Y cells. Neurosci. Lett. 481, 154-158.
64. Zhu, X., Raina, A. K., Lee, H. G., Chao, M., Nunomura, A., et al. (2003) Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. Antioxid. Redox Signal 5, 571-576. (Pubitemid 37315144)
65. Lagalwar, S., Guillozet-Bongaarts, A. L., Berry, R. W., and, Binder, L. I., (2006) Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 455-464. (Pubitemid 44297267)
66. Thakur, A., Wang, X., Siedlak, S. L., Perry, G., Smith, M. A., et al. (2007) c-Jun phosphorylation in Alzheimer disease. J. Neurosci. Res. 85, 1668-16673.
67. Pugazhenthi, S., Phansalkar, K., Audesirk, G., West, A., and, Cabell, L., (2006) Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal. Free Radic. Biol. Med. 40, 21-34. (Pubitemid 41759400)
68. Kanzawa, T., Iwado, E., Aoki, H., Iwamaru, A., Hollingsworth, E. F., et al. (2006) Ionizing radiation induces apoptosis and inhibits neuronal differentiation in rat neural stem cells via the c-Jun NH2-terminal kinase (JNK) pathway. Oncogene 25, 3638-3648. (Pubitemid 43980485)
69. Zhang, Q. G., Wu, D. N., Han, D., and, Zhang, G. Y., (2007) Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury. FEBS Lett. 581, 495-505. (Pubitemid 46149625)
70. Martisova, E., Solas, M., Gereñu, G., Milagro, F. I., Campion, J., et al. (2012) Mechanisms involved in BACE upregulation associated to stress. Curr. Alzheimer Res. Epub ahead of print.
71. Puig, B., Gõmez-Isla, T., Ribé, E., Cuadrado, M., Torrejõn-Escribano, B., et al. (2004) Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice. Neuropathol. Appl. Neurobiol. 30, 491-502. (Pubitemid 39423036)
72. Pearson, A. G., Byrne, U. T., MacGibbon, G. A., Faull, R. L., and, Dragunow, M., (2006) Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Neurosci. Lett. 398, 246-250. (Pubitemid 43673710)
73. Tatebayashi, Y., Planel, E., Chui, D. H., Sato, S., Miyasaka, T., et al. (2006) c-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis. FASEB J. 20, 762-764. (Pubitemid 46671207)
74. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and, Strittmatter, S. M., (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-11132.
75. Bu, G., Cam, J., and, Zerbinatti, C., (2006) LRP in amyloid-beta production and metabolism. Ann. N Y Acad. Sci. 1086, 35-53.
76. De Pietri Tonelli, D., Mihailovich, M., Di Cesare, A., Codazzi, F., and, Grohovaz, F., (2004) Translational regulation of BACE-1 expression in neuronal and non-neuronal cells. Nucleic. Acids Res. 32, 1808-1817. (Pubitemid 38832726)
77. Wong, P. C., (2008) Translational control of BACE1 may go awry in Alzheimer's disease. Neuron 60, 941-943.
78. Lammich, S., Schöbel, S., Zimmer, A. K., Lichtenthaler, S. F., and, Haass, C., (2004) Expression of the Alzheimer protease BACE1 is suppressed via its 5'-untranslated region. EMBO Rep. 5, 620-625. (Pubitemid 39139534)
79. O'Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., et al. (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60, 988-1009.
80. Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., and, Das, S., (2007) Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 54, 721-737. (Pubitemid 46843521)
81. Koh, Y. H., von Arnim, C. A., Hyman, B. T., Tanzi, R. E., and, Tesco, G., (2005) BACE is degraded via the lysosomal pathway. J. Biol. Chem. 280, 32499-32504. (Pubitemid 41361863)
82. He, X., Li, F., Chang, W. P., and, Tang, J., (2005) GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J. Biol. Chem. 280, 11696-11703. (Pubitemid 40418483)
83. He, X., Zhu, G., Koelsch, G., Rodgers, K. K., Zhang, X. C., et al. (2003) Biochemical and structural characterization of the interaction of memapsin 2 (beta-secretase) cytosolic domain with the VHS domain of GGA proteins. Biochemistry 42, 12174-12180. (Pubitemid 37296493)
84. Wahle, T., Prager, K., Raffler, N., Haass, C., Famulok, M., et al. (2005) GGA proteins regulate retrograde transport of BACE1 from endosomes to the trans-Golgi network. Mol. Cell Neurosci. 29, 453-461. (Pubitemid 40799217)
85. Kang, E. L., Cameron, A. N., Piazza, F., Walker, K. R., and, Tesco, G., (2010) Ubiquitin regulates GGA3-mediated degradation of BACE1. J. Biol. Chem. 285, 24108-24119.
86. Puertollano, R., and, Bonifacino, J. S., (2004) Interactions of GGA3 with the ubiquitin sorting machinery. Nat. Cell Biol. 6, 244-251. (Pubitemid 38344363)
87. Deng, Y., Guo, Y., Watson, H., Au, W. C., Shakoury-Elizeh, M., et al. (2009) Gga2 mediates sequential ubiquitin-independent and ubiquitin-dependent steps in the trafficking of ARN1 from the trans-Golgi network to the vacuole. J. Biol. Chem. 284, 23830-23841.
88. Wildasin, K., (2004) Role of reticulon proteins in Alzheimer's disease. Lancet Neurol. 3, 576.
89. Masliah, E., Xie, F., Dayan, S., Rockenstein, E., Mante, M., et al. (2010) Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice. Neuroscience 169, 488-494.
90. Araki, W., Oda, A., Motoki, K., Hattori, K., Itoh, M., et al. (2012) Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice. Curr. Alzheimer Res. Epub ahead of print.
91. Faghihi, M. A., Modarresi, F., Khalil, A.M., Wood, D. E., Sahagan, B. G., et al. (2008) Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 14, 723-730.
92. Mowrer, K. R., and, Wolfe, M. S., (2008) Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production. J. Biol. Chem. 283, 18694-18701.
93. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., et al. (2003) APP processing and synaptic function. Neuron 37, 925-937. (Pubitemid 36398299)
94. De Taboada, L., Yu, J., El-Amouri, S., Gattoni-Celli, S., Richieri, S., et al. (2011) Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice. J. Alzheimers Dis. 23, 521-535.
95. Gatta, V., Drago, D., Fincati, K., Valenti, M. T., Dalle Carbonare, L., et al. (2011) Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex. PLoS One 6, e15965.
96. Piccini, A., Borghi, R., Guglielmotto, M., Tamagno, E., Cirmena, G., et al. (2012) β-Amyloid 1-42 induces physiological transcriptional regulation of BACE1. J. Neurochem. 122, 1023-1031.
97. Mira, E., and, Castano, J. G., (1989) Insulin short-term control of rat liver alpha 2-microglobulin gene transcription. J. Biol. Chem. 264, 18209-18212. (Pubitemid 19279294)
98. Guglielmotto, M., Monteleone, D., Boido, M., Piras, A., Giliberto, L., et al. (2012) Aβ 1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation. Aging Cell. 11, 834-844.
99. Wilkinson, K. D., Lee, K. M., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., et al. (1989) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246, 670-673. (Pubitemid 19283361)
100. Gong, B., and, Leznik, E., (2007) The role of ubiquitin C-terminal hyrolase L1 in neurodegenerative disorders. Drug News Perspect. 20, 365-370. (Pubitemid 350219068)
101. Pasinetti, G. M., (2001) Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J. Neurosci. Res. 65, 471-476. (Pubitemid 32847139)
102. Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., et al. (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279, 13256-13264. (Pubitemid 38445905)
103. Ichihara, N., Wu, J., Chui, D. H., Yamazaki, K., Wakabayashi, T., et al. (1995) Axonal degeneration promotes abnormal accumulation of amyloid beta-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res. 695, 173-178.
104. Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., et al. (2006) Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775-788. (Pubitemid 44233627)
105. Trinchese, F., Liu, S., Battaglia, F., Walter, S., Mathews, P. M., et al. (2004) Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann. Neurol. 55, 801-814. (Pubitemid 38702575)
106. Tong, L., Thornton, P. L., Balazs, R., and, Cotman, C. W., (2001) Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J. Biol. Chem. 276, 17301-17306.
107. Zhang, M., Deng, Y., Luo, Y., Zhang, S., Zou, H., et al. (2012) Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1. J. Neurochem. 120, 1129-1138.
108. Wang, R., Zhang, M., Zhou, W., Ly, P. T., Cai, F., et al. (2011) NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression. J. Neurochem. 116, 1160-1170.
109. Cuervo, A. M., (2004) Autophagy: in sickness and in health. Trends Cell. Biol. 14, 70-77. (Pubitemid 38186640)
110. Lee, J. A., (2009) Autophagy in neurodegeneration: two sides of the same coin. BMB Rep. 42, 324-330.
111. Cardoso, S. M., Pereira, C. F., Moreira, P. I., Arduino, D. M., Esteves, A. R., et al. (2010) Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease. Exp. Neurol. 223, 294-298.
112. Yang, D. S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., et al. (2011) Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. Autophagy 7, 788-789.
113. Nixon, R. A., and, Cataldo, A. M., (2006) Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. J. Alzheimers Dis. 9, 277-289. (Pubitemid 44253321)